Founded by Genzyme, an international business of care, specialized on rare diseases, oncology, multiple sclerosis and immunology. SYNVISC® provides rapid and long-lasting relief, with efficacy demonstrated for up to six months for chronic OA knee pain. Clinical studies have shown significant pain reduction as early as one week post-treatment, sustained through 12 months.